|
WO2015164330A1
(en)
|
2014-04-21 |
2015-10-29 |
Millennium Pharmaceuticals, Inc. |
Anti-psyk antibody molecules and use of same for syk-targeted therapy
|
|
MX2010011463A
(es)
|
2008-04-16 |
2011-06-03 |
Portola Pharm Inc |
2,6-diamino-pirimidin-5-il-carboxamidas como inhibidores de syk o jak quinasas.
|
|
US8138339B2
(en)
|
2008-04-16 |
2012-03-20 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
US11351168B1
(en)
|
2008-06-27 |
2022-06-07 |
Celgene Car Llc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
US8338439B2
(en)
*
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
SG10201510696RA
(en)
|
2008-06-27 |
2016-01-28 |
Celgene Avilomics Res Inc |
Heteroaryl compounds and uses thereof
|
|
ES2433109T3
(es)
*
|
2009-01-13 |
2013-12-09 |
Glaxo Group Limited |
Derivados de pirimidin-carboxamida como inhibidores de la Syk cinasa
|
|
JP5918693B2
(ja)
|
2009-05-05 |
2016-05-18 |
ダナ ファーバー キャンサー インスティテュート インコーポレイテッド |
Ｅｇｆｒ阻害剤及び疾患の治療方法
|
|
CA2760061C
(en)
*
|
2009-05-08 |
2017-02-28 |
Astellas Pharma Inc. |
Diamino heterocyclic carboxamide compound
|
|
US8410126B2
(en)
*
|
2009-05-29 |
2013-04-02 |
Boehringer Ingelheim International Gmbh |
Pyrimidine inhibitors of PKTK2
|
|
AU2010333804B2
(en)
|
2009-12-23 |
2015-07-16 |
Takeda Pharmaceutical Company Limited |
Fused heteroaromatic pyrrolidinones as syk inhibitors
|
|
PL2589592T3
(pl)
|
2010-06-30 |
2019-03-29 |
Fujifilm Corporation |
Nowe pochodne nikotynamidu lub ich sole
|
|
MY160734A
(en)
|
2010-08-10 |
2017-03-15 |
Celgene Avilomics Res Inc |
Besylate salt of a btk inhibitor
|
|
KR20130108318A
(ko)
|
2010-08-27 |
2013-10-02 |
메르크 파텐트 게엠베하 |
푸로피리딘 유도체들
|
|
KR20130110163A
(ko)
|
2010-08-27 |
2013-10-08 |
메르크 파텐트 게엠베하 |
트리아졸로피라진 유도체들
|
|
JP2014005206A
(ja)
*
|
2010-10-22 |
2014-01-16 |
Astellas Pharma Inc |
アリールアミノヘテロ環カルボキサミド化合物
|
|
NZ710636A
(en)
|
2010-11-01 |
2017-02-24 |
Celgene Avilomics Res Inc |
Heterocyclic compounds and uses thereof
|
|
US20130317029A1
(en)
*
|
2010-11-01 |
2013-11-28 |
Portola Pharmaceuticals, Inc. |
Oxypyrimidines as syk modulators
|
|
AU2011323484B2
(en)
|
2010-11-01 |
2016-10-06 |
Portola Pharmaceuticals, Inc. |
Benzamides and nicotinamides as Syk modulators
|
|
WO2012061303A1
(en)
|
2010-11-01 |
2012-05-10 |
Avila Therapeutics, Inc. |
Heteroaryl compounds and uses thereof
|
|
EP2489663A1
(en)
|
2011-02-16 |
2012-08-22 |
Almirall, S.A. |
Compounds as syk kinase inhibitors
|
|
AU2012245387C1
(en)
|
2011-04-22 |
2016-05-05 |
Signal Pharmaceuticals, Llc |
Substituted Diaminocarboxamide and Diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
|
|
AU2016244228B2
(en)
*
|
2011-04-22 |
2019-02-21 |
Signal Pharmaceuticals, Llc |
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
|
|
WO2012154518A1
(en)
|
2011-05-10 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as syk inhibitors
|
|
EP2706853B1
(en)
|
2011-05-10 |
2017-06-14 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as syk inhibitors
|
|
JP2014513687A
(ja)
|
2011-05-10 |
2014-06-05 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Ｓｙｋ阻害薬としてのピリジルアミノピリジン
|
|
WO2012177714A1
(en)
|
2011-06-22 |
2012-12-27 |
Takeda Pharmaceutical Company Limited |
Substituted 6-aza-isoindolin-1-one derivatives
|
|
WO2013052391A1
(en)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
PHENYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
EP2763976B1
(en)
*
|
2011-10-05 |
2016-05-18 |
Merck Sharp & Dohme Corp. |
2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
|
US8987456B2
(en)
|
2011-10-05 |
2015-03-24 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
|
CA2853498A1
(en)
|
2011-10-28 |
2013-05-02 |
Celgene Avilomics Research, Inc. |
Methods of treating a bruton's tyrosine kinase disease or disorder
|
|
WO2013066729A1
(en)
*
|
2011-10-31 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
|
|
CA2856306A1
(en)
*
|
2011-11-23 |
2013-05-30 |
Portola Pharmaceuticals, Inc. |
Selective kinase inhibitors
|
|
SG11201402570QA
(en)
|
2011-11-23 |
2014-06-27 |
Portola Pharm Inc |
Pyrazine kinase inhibitors
|
|
RU2576623C2
(ru)
|
2011-12-28 |
2016-03-10 |
Фуджифилм Корпорэйшн |
Новое производное никотинамида или его соль
|
|
WO2013104573A1
(en)
*
|
2012-01-10 |
2013-07-18 |
F. Hoffmann-La Roche Ag |
Pyridazine amide compounds and their use as syk inhibitors
|
|
TWI532727B
(zh)
*
|
2012-01-17 |
2016-05-11 |
安斯泰來製藥股份有限公司 |
吡羧醯胺化合物
|
|
US20150038527A1
(en)
|
2012-02-21 |
2015-02-05 |
Merck Patent Gmbh |
Furopyridine derivatives
|
|
ES2674451T3
(es)
|
2012-02-21 |
2018-06-29 |
Merck Patent Gmbh |
2-amino-[1,2,4]triazolo[1,5-a] pirazinas 8-sustituidos como inhibidores de la SYK tirosina quinasa e inhibidores de la serina quinasa GCN2
|
|
UY34807A
(es)
*
|
2012-05-16 |
2013-12-31 |
Novartis Ag |
Derivados monocíclicos de heteroarilcicloalquil- diamina
|
|
WO2013192128A1
(en)
|
2012-06-20 |
2013-12-27 |
Merck Sharp & Dohme Corp. |
Imidazolyl analogs as syk inhibitors
|
|
US9242984B2
(en)
|
2012-06-20 |
2016-01-26 |
Merck Sharp & Dohme Corp. |
Pyrazolyl derivatives as Syk inhibitors
|
|
US20140113931A1
(en)
*
|
2012-06-22 |
2014-04-24 |
Portola Pharmaceuticals, Inc. |
Substituted picolinamide kinase inhibitors
|
|
EP2863916B1
(en)
|
2012-06-22 |
2018-07-18 |
Merck Sharp & Dohme Corp. |
Substituted pyridine spleen tyrosine kinase (syk) inhibitors
|
|
US9040530B2
(en)
*
|
2012-06-22 |
2015-05-26 |
Portola Pharmaceuticals, Inc. |
1,2,4-triazine-6-carboxamide kinase inhibitors
|
|
WO2013192088A1
(en)
|
2012-06-22 |
2013-12-27 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
EP2882746B1
(en)
|
2012-08-07 |
2016-12-07 |
Merck Patent GmbH |
Pyridopyrimidine derivatives as protein kinase inhibitors
|
|
WO2014031438A2
(en)
|
2012-08-20 |
2014-02-27 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
|
EP2897950A1
(en)
|
2012-09-18 |
2015-07-29 |
Ziarco Pharma Ltd |
2-(2-aminocyclohexyl)amino-pyrimidine-5-carboxamides as spleen tyrosine kinasei(syk) inhibitors
|
|
EP2900665B1
(en)
|
2012-09-28 |
2018-01-03 |
Merck Sharp & Dohme Corp. |
Triazolyl derivatives as syk inhibitors
|
|
RU2641916C2
(ru)
|
2012-10-02 |
2018-01-23 |
Байер Кропсайенс Аг |
Гетероциклические соединения в качестве пестицидов
|
|
WO2014060371A1
(en)
*
|
2012-10-19 |
2014-04-24 |
F. Hoffmann-La Roche Ag |
Inhibitors of syk
|
|
SG11201503395TA
(en)
*
|
2012-11-08 |
2015-05-28 |
Bristol Myers Squibb Co |
ALKYL AMIDE-SUBSTITUTED PYRIMIDINE COMPOUNDS USEFUL IN THE MODULATION OF IL-12, IL-23 AND/OR IFNα
|
|
US9624210B2
(en)
|
2012-12-12 |
2017-04-18 |
Merck Sharp & Dohme Corp. |
Amino-pyrimidine-containing spleen tyrosine kinase (Syk) inhibitors
|
|
US9126950B2
(en)
|
2012-12-21 |
2015-09-08 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
|
EP2934525B1
(en)
|
2012-12-21 |
2019-05-08 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
|
|
US9561228B2
(en)
|
2013-02-08 |
2017-02-07 |
Celgene Avilomics Research, Inc. |
ERK inhibitors and uses thereof
|
|
WO2014152768A1
(en)
*
|
2013-03-15 |
2014-09-25 |
Portola Pharmaceuticals, Inc. |
Cyclohexanediamine compounds and methods for their preparation
|
|
JP2016113366A
(ja)
*
|
2013-03-29 |
2016-06-23 |
大鵬薬品工業株式会社 |
アセトアミド基を有する１，２，４−トリアジン−６−カルボキサミド誘導体
|
|
EP2988749B1
(en)
|
2013-04-26 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
|
|
EP2988744A4
(en)
|
2013-04-26 |
2016-11-02 |
Merck Sharp & Dohme |
THIAZOLSUBSTITUTED AMINOHETEROARYLE AS MILZTYROSINKINASE INHIBITOR
|
|
US9556148B2
(en)
|
2013-08-07 |
2017-01-31 |
Cadila Healthcare Limited |
N-cyanomethylamides as inhibitors of janus kinase
|
|
US9492471B2
(en)
|
2013-08-27 |
2016-11-15 |
Celgene Avilomics Research, Inc. |
Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
|
|
WO2015039613A1
(zh)
*
|
2013-09-18 |
2015-03-26 |
北京韩美药品有限公司 |
抑制btk和/或jak3激酶活性的化合物
|
|
JP6345786B2
(ja)
|
2013-12-05 |
2018-06-20 |
ファーマサイクリックス エルエルシー |
ブルトン型チロシンキナーゼの阻害剤
|
|
WO2015094997A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
US9670196B2
(en)
|
2013-12-20 |
2017-06-06 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors
|
|
EP3083559B1
(en)
|
2013-12-20 |
2021-03-10 |
Merck Sharp & Dohme Corp. |
Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
|
|
NZ715903A
(en)
|
2014-01-30 |
2017-06-30 |
Signal Pharm Llc |
Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
|
|
EP3116506B1
(en)
|
2014-03-13 |
2019-04-17 |
Merck Sharp & Dohme Corp. |
2-pyrazine carboxamides as spleen tyrosine kinase inhibitors
|
|
WO2016020403A1
(en)
*
|
2014-08-04 |
2016-02-11 |
Sandoz Ag |
Preparation of a benzoic acid derivative and its use for the preparation of suvorexant
|
|
US10005760B2
(en)
|
2014-08-13 |
2018-06-26 |
Celgene Car Llc |
Forms and compositions of an ERK inhibitor
|
|
ES2877642T3
(es)
|
2014-12-16 |
2021-11-17 |
Signal Pharm Llc |
Formulaciones de 2-(terc-butilamino)-4-((1R,3R,4R)-3-hidroxi-4-metilciclohexilamino)-pirimidin-5-carboxamida
|
|
WO2016100308A1
(en)
|
2014-12-16 |
2016-06-23 |
Signal Pharmaceuticals, Llc |
Methods for measurement of inhibition of c-jun n-terminal kinase in skin
|
|
US20180022710A1
(en)
|
2015-01-29 |
2018-01-25 |
Signal Pharmaceuticals, Llc |
Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
|
|
EP3795553B1
(en)
|
2015-07-24 |
2024-05-15 |
Celgene Corporation |
Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein
|
|
ES2913119T3
(es)
*
|
2015-08-12 |
2022-05-31 |
Portola Pharm Inc |
Cerdulatinib para tratar mieloma
|
|
KR102571679B1
(ko)
*
|
2016-04-15 |
2023-08-29 |
에피자임, 인코포레이티드 |
Ehmt1 및 ehmt2 저해제로서의 아민-치환된 아릴 또는 헤테로아릴 화합물
|
|
WO2018108704A1
(en)
*
|
2016-12-13 |
2018-06-21 |
Boehringer Ingelheim International Gmbh |
New 6-amino-quinolinone compounds and derivatives as bcl6 inhibitors
|
|
CN118021814A
(zh)
|
2017-04-21 |
2024-05-14 |
Epizyme股份有限公司 |
用ehmt2抑制剂进行的组合疗法
|
|
CN109384774B
(zh)
*
|
2017-08-11 |
2023-02-17 |
中国科学院上海药物研究所 |
一类多取代的吡嗪/三嗪酰胺类化合物及其制备方法和应用
|
|
CA3079292A1
(en)
|
2017-10-19 |
2019-04-25 |
Bayer Animal Health Gmbh |
Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals
|
|
US10683297B2
(en)
*
|
2017-11-19 |
2020-06-16 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
KR20210018193A
(ko)
*
|
2018-03-09 |
2021-02-17 |
포톨라 파마슈티컬스, 인코포레이티드 |
선택적 syk 억제자의 사용 방법 및 약학적 조성물
|
|
UA127357C2
(uk)
|
2018-04-18 |
2023-07-26 |
Констеллатіон Фармацеутікалс, Інк. |
Модулятори метилмодифікуючих ферментів, композиції та їх використання
|
|
EP3797108B1
(en)
|
2018-05-21 |
2022-07-20 |
Constellation Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
|
DK3870579T3
(da)
|
2018-10-22 |
2025-01-02 |
Alumis Inc |
Tyk2-inhibitorer og anvendelser deraf
|
|
BR112021018168B1
(pt)
|
2019-03-21 |
2023-11-28 |
Onxeo |
Composição farmacêutica, combinação e kit compreendendo uma molécula dbait e um inibidor de quinase para o tratamento de câncer
|
|
MD4003532T2
(ro)
|
2019-07-24 |
2025-01-31 |
Constellation Pharmaceuticals Inc |
Forme cristaline de 7-clor-2-(4-(3-metoxiazetidin-1-il)ciclohexil)-2,4-dimetil-N-((6-metil-4-(metiltio)-2-oxo-1,2-dihidropiridin-3-il)metil)benzo[d][1,3]dioxol-5-carboxamidă
|
|
CA3159348A1
(en)
|
2019-11-08 |
2021-05-14 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
|
|
WO2021148581A1
(en)
|
2020-01-22 |
2021-07-29 |
Onxeo |
Novel dbait molecule and its use
|
|
US20230090742A1
(en)
*
|
2020-01-30 |
2023-03-23 |
Sumitomo Pharma Oncology, Inc. |
Aminopyrimidinylaminobenzonitrile derivatives as nek2 inhibitors
|
|
TW202227418A
(zh)
*
|
2020-10-12 |
2022-07-16 |
大陸商四川海思科製藥有限公司 |
一種雜環衍生物及其在醫藥上的應用
|
|
WO2022098809A1
(en)
*
|
2020-11-09 |
2022-05-12 |
Merck Sharp & Dohme Corp. |
Diaminopyrimidine carboxamide inhibitors of hpk1
|
|
TW202246233A
(zh)
|
2021-02-19 |
2022-12-01 |
英商蘇多生物科學有限公司 |
Tyk2抑制劑及其用途
|
|
TW202246232A
(zh)
*
|
2021-02-19 |
2022-12-01 |
英商蘇多生物科學有限公司 |
Ｔｙｋ２抑制劑及其用途
|
|
WO2022175745A1
(en)
*
|
2021-02-19 |
2022-08-25 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
EP4294806A1
(en)
*
|
2021-02-19 |
2023-12-27 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
CA3224094A1
(en)
*
|
2021-03-09 |
2022-09-15 |
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd |
Use of tricyclic heteroaryl-containing compound
|
|
CN115197196B
(zh)
*
|
2021-04-06 |
2024-06-18 |
扬子江药业集团有限公司 |
Tyk2抑制剂及其用途
|
|
WO2023108536A1
(en)
*
|
2021-12-16 |
2023-06-22 |
Lynk Pharmaceuticals Co. Ltd. |
Tyk2 inhibitors and compositions and methods thereof
|
|
AU2022412835A1
(en)
*
|
2021-12-16 |
2024-06-20 |
Lynk Pharmaceuticals Co. Ltd. |
Tyk2 inhibitors and compositions and methods thereof
|
|
CN116120282B
(zh)
*
|
2022-08-04 |
2024-02-20 |
苏州系统医学研究所 |
具有ev71和/或cva16病毒抑制活性的化合物及其应用
|
|
CN116925053A
(zh)
*
|
2023-07-26 |
2023-10-24 |
成都赜灵生物医药科技有限公司 |
甲磺酸普依司他中间体的杂质去除工艺
|
|
CN118440052B
(zh)
*
|
2024-07-05 |
2024-10-11 |
四川大学 |
一种化合物及其在制备tyk2激酶抑制剂中的用途
|